Registry for patients with CABP2-related hearing impairment
Official title: Patient Registry for Individuals With CABP2-Associated Hearing Loss
Run by University Medical Center Goettingen · NCT06680934 · Data updated 2026-11-12
This study is collecting information from people with hearing loss caused by CABP2 gene changes to learn more about this condition and how it affects them.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University Medical Center Goettingen Academic / other |
| Locations | 1 site (Göttingen) |
| Status | Recruiting |
| Started | August 16, 2024 |
| Main results expected | August 16, 2049 |
| Study ends | August 16, 2049 |
| Registry record updated | January 27, 2026 |
| Trial ID | NCT06680934 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals with a confirmed molecular genetic diagnosis of biallelic variants in the CABP2 gene and associated audiometry results.
✕Probably not a fit
Patients with hearing impairment due to non-CABP2 genetic causes will not benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This registry collects detailed information about individuals diagnosed with hearing impairment due to CABP2 gene variants. It aims to gather molecular genetic data and clinical information to support a natural history study of this condition. The study is conducted in both German and English and adheres to ethical guidelines approved by the University Medical Center Goettingen's Ethics Committee.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of CABP2-related hearing impairment and improve patient management.
How similar studies have gone: While this registry approach is common in genetic research, the specific focus on CABP2-related auditory synaptopathy is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * A molecular genetic diagnosis involving biallelic variants in CAPB2 and audiometry Exclusion Criteria: * Patients with evidence of non-CABP2 molecular genetic diagnoses
Where it's running
-
University Medical Center Goettingen
Göttingen, Germany Recruiting
Study contacts
- Principal investigator: Bernd Wollnik, MD — University Medical Center Goettingen
- Study coordinator: Barbara Vona, PhD
- Email: barbara.vona@med.uni-goettingen.de
- Phone: +49-551-38-51337
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Clemastine plus engineered sound to improve hearing in noisy environments for age-related central auditory processing disorder
This trial will test whether taking clemastine while listening to engineered sounds helps people aged 45–65 with age-related central auditory processing disorder hear better in noisy places.
-
Evaluating a new frequency allocation for cochlear implant users
This study is testing whether a new sound setting for cochlear implant users can improve their hearing experience and satisfaction compared to the standard setting.
-
Registry for patients with otoferlin-related hearing impairment
This study is collecting information from people with otoferlin-related hearing loss to better understand the condition and help improve future treatments.
-
Improving hearing tests for infants with hearing loss using brain imaging
This study tests if a new brain imaging technique can help audiologists make better decisions for infants with hearing loss while also checking if parents find the testing comfortable and acceptable.
-
Evaluating a noise reduction algorithm for cochlear implant users
This study is testing a new noise reduction tool to see if it helps people aged 12 and older with cochlear implants understand speech better in noisy places.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.